Effect of thyroparathyroidectomy on urinary acidification in diabetic rats by Gil, Frida Zaladek et al.
107
Braz J Med Biol Res 32(1) 1999
Diabetes and thyroparathyroidectomyBrazilian Journal of Medical and Biological Research (1999) 32: 107-113
ISSN 0100-879X
Effect of thyroparathyroidectomy on
urinary acidification in diabetic rats
Departamento de Fisiologia, Escola Paulista de Medicina,







In previous studies we have shown stimulation of renal acid excretion
in the proximal tubules of rats with diabetes of short duration, with no
important alterations in glomerular hemodynamics; on the other hand,
in thyroparathyroidectomized rats (TPTX model), a significant de-
crease in renal acid excretion, glomerular filtration rate (GFR) and
renal plasma flow (RPF) was detected. Since important changes in the
parathyroid hormone-vitamin D-Ca axis are observed in the diabetic
state, the present study was undertaken to investigate the renal reper-
cussions of thyroparathyroidectomy in rats previously made diabetic
by streptozotocin (45 mg/kg). Four to 6 days after the induction of
diabetes (DM), a group of rats were thyroparathyroidectomized (DM
+ TPTX). Renal functional parameters were evaluated by measuring
the inulin and sodium para-aminohippurate clearance on the tenth day.
The decrease in the GFR and RPF observed in TPTX was not reversed
by diabetes since the same alterations were observed in DM + TPTX.
Net acid (NA) excretion was unchanged in DM (6.19 – 0.54), de-
creased in TPTX (3.76 – 0.25) and returned to normal levels in DM +
TPTX (5.54 – 0.72) when compared to the control group (6.34 – 0.14
µmol min-1 kg-1). The results suggest that PTH plays an important
vasodilator role regarding glomerular hemodynamics, since in its
absence the impairment in GFR and RPF was not reversed by the
diabetic state. However, with respect to acid excretion, the presence of
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The mechanism of urinary acidification
has been shown to be altered in several
diseases, as well as in experimental models.
In a previous study, we showed that an in-
crease in the rate of proximal tubular acidifi-
cation was demonstrable in rats made dia-
betic (DM) by intraperitoneal administration
of streptozotocin (1) while a significant de-
crease in this parameter was observed in the
thyroparathyroidectomized (TPTX) rat model
(2). Several factors interfere with the activity
of the Na+/H+ exchanger, among them acid-
base status (3-6) and hormonal stimuli (2,7),
as well as pathophysiological situations (8,9).
The presence of diabetes has been shown to
be responsible for a number of alterations in
108
Braz J Med Biol Res 32(1) 1999
F. Zaladek-Gil et al.
metabolic pathways which include stimula-
tion of proximal tubular Na+ reabsorption
(10), renal tubular activity of Na+-K+-ATPase
(11,12) and protein kinase activity (13,14).
On the other hand, hyperparathyroidism has
been associated with both metabolic acido-
sis and alkalosis. Pollock et al. (15) showed
that parathyroid hormone (PTH) inhibits Na+
and volume reabsorption in the proximal
tubule, which could lead to metabolic acido-
sis, while Bichara et al. (16) proposed that
hyperparathyroidism could cause metabolic
alkalosis of renal origin since the hormone
stimulated the tubular excretion of ammo-
nium and titratable acidity.
Since disturbances in PTH and Ca2+ me-
tabolism are frequently reported in the dia-
betic state (17,18) and that secondary hyper-
parathyroidism which accompanies chronic
renal failure is associated with derangements
in insulin release (19), the present study was
designed to focus on the effects of both DM
and TPTX on renal functional parameters,
with special emphasis on urinary acidifica-
tion.
Material and Methods
Male Wistar rats weighing 200 to 300 g
were obtained from Escola Paulista de
Medicina, Sªo Paulo, Brazil. They received
a rat pellet diet and water ad libitum until the
time of the experiments. Diabetes was in-
duced by intraperitoneal (ip) injection of 45
mg/kg streptozotocin (STZ) 10 days before
the experiments, and prepared in citrate
buffer, pH 4.0. The induction of diabetes
was confirmed by measuring glycemia 5-6
days after drug administration. The rats that
presented glycemia below 280 mg% were
not used in the study. Thyroparathyroidec-
tomy was then performed under ether anes-
thesia and was considered successful only
when total plasma calcium concentration fell
by 1.75 mg/dl or more from preoperative
levels, 24 h after surgery. The following
groups were studied: sham-operated control
group (C) (N = 9), DM rats (N = 9), TPTX
rats (N = 9) and DM + TPTX (N = 9).
Thyroxin, 1 µg/100 g body weight, was
given by subcutaneous injection to TPTX
rats, every 24 h. This dose has been shown to
be necessary to reach euthyroidism (2). At
the time of the experiments, the animals
were anesthetized with Inactin (Byk-Gul-
den, Konstanz, Germany), 100 mg/kg ip, and
prepared for clearance measurements.
Briefly, the jugular vein, carotid artery and
urinary bladder were cannulated for infusion
and blood and urine withdrawal, respectively.
A tracheotomy was performed.
Clearance measurements
To evaluate the glomerular filtration rate
(GFR) and the renal plasma flow (RPF),
after a priming dose of inulin and sodium p-
aminohippurate (PAH), 30 mg/100 g and 2
mg/rat, respectively, the infusion of a sus-
taining dose of inulin, 0.05 mg min-1 100 g-1,
and of PAH, 40 mg/10 ml, in isotonic saline
was initiated at a rate of 0.06 ml/min. After a
stabilization period of 30 min, four clear-
ance periods of 30 min were studied. Blood
samples were obtained at the midpoint of
each clearance period. Urine was collected
quantitatively in preweighed containers, and
urine volume was determined gravimetri-
cally. Inulin concentration in plasma and
urine was measured by the method of Fuehr
et al. (20) and PAH concentration in plasma
and urine by the method of Smith et al. (21),
both adapted for smaller plasma and urine
volumes. Urine and plasma Na+ and K+ con-
centrations were determined with an Na+/K+
analyzer, model 248 (Ciba-Corning Diag-
nostics Ltd., Essex, England). Urine and
blood pH, pCO2 and bicarbonate values were
obtained with a Ciba-Corning, model 614
blood gas analyzer. Titratable acidity (TA)
in urine was measured by microtitration and
ammonium excretion (NH4+) by the spectro-
photometric method of Connerty et al. (22).
Net acid (NA) excretion was calculated by
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 is the excreted amount of bi-
carbonate. Ionized calcium was measured
with a calcium-selective electrode, model
9140 (AVL Scientific Corporation, Roswell,
NM, USA). Total calcium in plasma and
urine specimens was measured by a colori-
metric method.
Statistical analysis
The results are reported as means – SEM
and were analyzed statistically by analysis of
variance followed by the ScheffØ test and by
the Kruskal-Wallis test followed by Dunns
post-test, when necessary, with the level of
significance set at 0.05.
Results
Streptozotocin induced an overt diabetic
state in the treated rats, as shown by the
mean glycemia values obtained for these
animals, i.e., 317.50 – 13.56 and 322.8 –
15.23 for DM and DM + TPTX rats, respec-
tively. These values were significantly higher
(P<0.001) than those of the control and TPTX
rats, 86.0 – 2.98 and 88.7 – 5.44 mg/dl,
respectively. The final body weight of the
studied groups was similar.
Table 1 shows the acid-base data for the
groups studied. Diabetic rats presented a
lower urine pH than that of the control group,
which suggests that acid excretion was stimu-
lated in this condition, probably due to the
acid overload produced by the metabolism
of the diabetic rats. In TPTX, although blood
HCO3- was decreased, urine pH was not
different from control values, suggesting that
a renal compensation mechanism was not
triggered.
As shown in Table 2, thyroparathyroi-
dectomy induced a significant decrease in
GFR, U/P inulin and in RPF; these alter-
ations were also present in DM + TPTX,
suggesting that in this model of acute dia-
betic state the vasoconstrictor stimulus, i.e.,
the absence of PTH, was preponderant over
glomerular hemodynamics. NA was un-
changed in DM when compared to control
values, as seen in Table 3. A significant
decrease in NA was obtained in TPTX,
mainly due to a decrease in titratable acidity;
in the DM + TPTX group, NA returned to
values not different from those for C and
DM, suggesting that the presence of DM was
a more potent stimulus of acid excretion than
the inhibition promoted by the absence of
PTH.
Table 1 - Acid-base data of control (C), diabetic (DM), thyroparathyroidecto-
mized (TPTX) and DM + TPTX rats.
Data are reported as means ± SEM for the number of measurements given
within parentheses. Significance level: *P<0.05 vs C; **P<0.05 vs DM;
+P<0.05 vs TPTX.
Group Blood pH Blood HCO3 (mEq/l) Urine pH
Control (15) 7.41 ± 0.01 20.05 ± 0.70 6.11 ± 0.06
DM (24) 7.38 ± 0.01 17.8 ± 0.83 5.88 ± 0.046*
TPTX (20) 7.40 ± 0.01 16.86 ± 0.52* 6.20 ± 0.04**
DM + TPTX (22) 7.35 ± 0.042 22.09 ± 0.78**+ 6.18 ± 0.046**
Table 2 - Renal function data in control (C), diabetic (DM), thyroparathyroidectomized (TPTX) and DM + TPTX
rats.
Data are reported as means ± SEM. The number of measurements is given within parentheses. GFR =
Glomerular filtration rate; U/P inulin = urine/plasma inulin ratio; RPF = renal plasma flow; V = urine flow; FF =
filtration fraction. *P<0.05 vs C; +P<0.05 vs DM.
Group GFR U/P RPF V FF
(ml min-1 kg-1) inulin (ml min-1 kg-1) (ml min-1 kg-1) (%)
Control (15) 7.79 ± 0.33 54.0 ± 3.5 20.7 ± 1.07 0.14 ± 0.011 35.75 ± 0.48
DM (24) 6.66 ± 0.58 40.4 ± 1.76* 18.41 ± 1.51 0.17 ± 0.009 36.1 ± 0.9
TPTX (20) 4.88 ± 0.26*+ 41.6 ± 2.41* 13.5 ± 0.80*+ 0.15 ± 0.007 33.54 ± 1.45
DM + TPTX (22) 5.29 ± 0.32* 33.57 ± 2.01*+ 14.19 ± 0.66*+ 0.16 ± 0.008 38.3 ± 1.22
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As seen in Table 4, diabetic rats showed
no alterations in Ca2+ metabolism. As ex-
pected, TPTX showed a significant decrease
in calcemia and an increase in the absolute
and relative levels of calcium excretion. Al-
though the presence of diabetes tended to
elevate the ionizable Ca2+ in the TPTX group,
the rates of calcium excretion remained in-
creased in DM + TPTX, suggesting that
diabetes was unable to change the tubular
handling of Ca2+ when PTH was absent.
Mean blood sodium and potassium lev-
els and the fractional excretion of these ions
are shown in Table 5. The fractional excre-
tion of Na+ was significantly increased in
TPTX and returned to normal values in DM
+ TPTX, suggesting that diabetes and thyro-
parathyroidectomy may have opposite ef-
fects concerning Na+ reabsorption. Diabetic
rats showed an increase in the fractional
excretion of K+, an alteration that could be
the result of osmotic diuresis and/or intracel-
lular acidosis; the same alterations were ob-
tained in the DM + TPTX group.
Discussion
A number of studies have shown that
vitamin D metabolism and tubular respon-
siveness to PTH are impaired in diabetic rat
models (17,18,23). Clinical studies have also
shown that, in diabetic patients on hemodi-
alysis, the magnitude of secondary hyper-
parathyroidism is generally lower than in
other dialysis patients (24) and the occur-
rence of low bone turnover which results in
adynamic bone disease is frequent (25). These
studies provide strong evidence that the rela-
tionship between insulin and the PTH-Ca2+
axis is complex and that several membrane
transporters may be affected by these hor-
mones.
Diabetes has been shown to be respon-
sible for a number of pathophysiological
Table 4 - Plasma (ionized and total) calcium and urinary calcium excretion in the groups studied.
C = Control; DM = diabetes mellitus; TPTX = thyroparathyroidectomized rats. Data are reported as
means ± SEM. The number of measurements is given within parentheses. *P<0.05 vs C; +P<0.05 vs
DM; **P<0.05 vs TPTX.
Group Ionized calcium Total plasma Excreted amount Fractional
(mEq/l) calcium (mg/dl) of calcium excretion
(mg min-1 kg-1) (%)
Control (9) 1.21 ± 0.01 8.29 ± 0.12 0.30 ± 0.02 0.56 ± 0.04
DM (9) 1.24 ± 0.01 7.88 ± 0.45 0.23 ± 0.054 0.47 ± 0.106
TPTX (9) 0.66 ± 0.05*+ 5.31 ± 0.66*+ 2.10 ± 0.31*+ 1.10 ± 0.16*+
DM + TPTX (9) 0.98 ± 0.08*+** 6.42 ± 0.54* 3.16 ± 0.21*+ 1.24 ± 0.20*+
Table 3 - Titratable acidity (TA), excreted ammonium (NH4+), excreted amount of bicarbonate (CHCO3
- )
and net acid (NA) excretion in the groups studied.
C = Control, DM = diabetes mellitus, TPTX = thyroparathyroidectomized rats. Data are reported as
means ± SEM.  The number of measurements is given within parentheses. *P<0.05 vs C; +P<0.05 vs
DM; **P<0.05 vs TPTX.
Group TA NH4+ CHCO3
- NA
(µEq min-1 kg-1) (µEq min-1 kg-1) (µEq min-1 kg-1) (µEq min-1 kg-1)
C (24) 2.41 ± 0.13 4.1 ± 0.34 0.12 ± 0.01 6.34 ± 0.14
DM (24) 2.78 ± 0.208 3.49 ± 0.36 0.08 ± 0.009 6.19 ± 0.541
TPTX (19) 1.48 ± 0.13*+ 2.49 ± 0.98 0.23 ± 0.04 3.76 ± 0.25*+
DM + TPTX (22) 2.43 ± 0.18** 3.32 ± 0.67 0.28 ± 0.08 5.54 ± 0.72**
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alterations in renal function, including modi-
fications in glomerular hemodynamics (26)
and in urinary acidification (1). The hyper-
filtrating state, with glomerular capillary hy-
pertension, may be one of the first alter-
ations caused by DM (27); however, in our
model diabetes was present for a short pe-
riod of time, probably insufficient to cause
significant changes in GFR and RPF. The
decrease in GFR and RPF observed in TPTX
confirms the action of PTH as a renal vasodi-
lator (28) and these changes persisted even
in the presence of DM, which theoretically
could protect renal arterioles against vaso-
constriction, suggesting that, concerning he-
modynamic effects, the effect of the absence
of PTH is preponderant over DM. These
alterations in glomerular hemodynamics were
previously shown in TPTX animals receiv-
ing or not oral calcium supplementation (2),
suggesting that the presence of PTH (and not
a normal calcemia) was fundamental to main-
tain the renal hemodynamics at normal lev-
els.
As shown by Carney and Gillies (29),
PTH may act as a partial agonist of arginine
vasopressin in the collecting system, which
means that in TPTX an impairment in the
urine-concentrating ability is not unexpected.
This effect, together with the osmotic diure-
sis of DM, could further decrease the U/P
inulin ratio, as observed in the DM + TPTX
animals.
Net acid excretion was significantly im-
paired in TPTX, but when rats were previ-
ously made diabetic, NA returned to values
observed in intact animals. In order to under-
stand these findings, it is important to dis-
cuss the known effects of diabetes mellitus
and thyroparathyroidectomy on urinary acidi-
fication. In micropuncture and microperfu-
sion experiments it has been demonstrated
that proximal tubular Na+ reabsorption is
increased in diabetes mellitus (30,31) and
that the proximal reabsorption rates of bicar-
bonate are stimulated (1); in the present
study, since the urinary flow as well as the
final body weight were unchanged, the lower
FENa+ seen in DM reflects an increased tubu-
lar reabsorption of Na+ rather than a de-
crease in the extracellular volume status. On
the other hand, previous studies from this
laboratory (32) have shown that the rates of
bicarbonate reabsorption in the proximal tu-
bule of TPTX rats were decreased to the
same extent as in a model of intact rats,
whose tubules were perfused with a solution
containing EGTA, an agent that chelates
calcium. Interestingly, when the proximal
tubules of TPTX were perfused with a cal-
cium ionophore added to the luminal side,
the reabsorption rates returned to normal
levels, pointing to an important role of cal-
cium as a mediator of luminal acidification.
In the present study, we observed that in the
diabetic state renal handling of calcium and
total as well as ionizable Ca2+ were within
the normal range, which means that in this
model of STZ-induced diabetes no signifi-
cant alterations in calcium metabolism oc-
curred. Moreover, diabetes did not change
the renal handling of Ca2+ in rats submitted
Table 5 - Blood Na+ and K+ and their fractional excretion in the groups studied.
C = Control; DM = diabetes mellitus; TPTX = thyroparathyroidectomized rats. Data are
reported as means ± SEM. The number of measurements is given within parentheses.
*P<0.05 vs C; **P<0.05 vs DM; +P<0.05 vs TPTX.
Group Na+ (mEq/l) FENa+% K+ (mEq/l) FEK+%
Control (24) 134.06 ± 1.53 0.85 ± 0.001 3.56 ± 0.08 20.78 ± 2.62
DM (20) 140.96 ± 0.71* 0.21 ± 0.02* 3.27 ± 0.12 32.91 ± 2.65*
TPTX (20) 145.25 ± 2.42* 1.11 ± 0.15*,** 4.90 ± 0.19** 19.39 ± 1.99**
DM + TPTX (22) 143.5 ± 0.81* 0.84 ± 0.10** 3.56 ± 0.08 40.99 ± 1.77*+
112
Braz J Med Biol Res 32(1) 1999
F. Zaladek-Gil et al.
to thyroparathyroidectomy. These findings
suggest that, concerning tubular handling of
Ca2+, the presence of hyperglycemia prob-
ably has no significant role in modulating
PTH effects, a conclusion also reached by
Wongsurawat and Armbrecht (33). Although
these investigators used a model in which
the induction of diabetes followed thyropar-
athyroidectomy (TPTX + DM), they con-
cluded that insulin did not modulate the PTH
effects with respect to calcemia and phos-
phaturia.
An important increase in the Na+/H+
antiport activity was observed in leukocytes
from diabetic animals, which was reversed
by incubation with staurosporine, a protein
kinase inhibitor, suggesting that protein ki-
nase activity (including PKC) may be higher
in diabetic subjects (13,14,34); PKC is also
stimulated when PTH binds to the basolateral
receptor in renal tubular cells, as shown by
Dumlay and Hruska (35). In this way, when
both conditions are present, DM + TPTX, an
equilibrium between a stimulating (diabe-
tes) and an inhibitory event (parathyroidec-
tomy) would be expected to bring acidifica-
tion to normal levels. The normal levels of
acidification obtained in DM + TPTX could
be also explained by taking into account the
known effects of both diabetes mellitus and
PTH on intracellular calcium levels [Ca2+]i.
In a recent study, Smogorzewski et al. (36)
conclude that when rat cardiac myocytes
were incubated in a high glucose medium, an
experimental model that simulates the dia-
betic state, a significant rise in [Ca2+]i was
observed, probably mediated by activation
of calcium channels and, to a lesser extent,
by activation of cAMP-protein kinase A. A
significant rise in [Ca2+]i was also observed
in rat polymorphonuclear cells incubated
with a high glucose medium (36). On the
other hand, PTH also causes a rise in [Ca2+]i
in many cells, including renal tubular cells
(37,38). Thus, a fall in [Ca2+]i could be
expected in TPTX. When both conditions
are present simultaneously, DM + TPTX, a
near normal cytosolic Ca2+ could be present,
resulting in an adequate luminal Na+/H+
antiport.
We have demonstrated that diabetic rats
submitted to thyroparathyroidectomy are able
to maintain a normal level of acid excretion
despite the impaired glomerular function.
The results suggest that glomeruli and tu-
bules may react differently to the same hor-
monal stimulus due to the predominance of
different receptors in these renal structures.
Our results may also suggest that the re-
ported altered sensitivity of the diabetic neph-
ron to the action of PTH may be regarded as
a compensatory mechanism which may pre-
vent an exacerbated response to this hor-
monal stimulus.
References
1. Nascimento Gomes G, Zaladek Gil F &
Mello-Aires M (1997). Alterations in renal
handling of H+ in diabetic rats. Kidney and
Blood Pressure Reseach, 20:  251-257.
2. Zaladek-Gil F, Costa-Silva VL, Cavanal MF
& Malnic G (1992). Effects of parathyroid
hormone and calcium and their interrela-
tionship on urinary acidification in the rat.
Clinical Science, 83: 711-715.
3. Preisig PA & Alpern RJ (1988). Chronic
metabolic acidosis causes an adaptation
in the apical membrane Na/H antiporter
and the basolateral membrane Na(HCO3)3
symporter in the rat proximal convoluted
tubule. Journal of Clinical Investigation,
82: 1445-1453.
4. Tsai CJ, Ives HE, Alpern RJ, Yee VJ,
Warnock DG & Rector Jr FC (1984). In-
creased Vmax for Na/H antiporter activity
in proximal tubule brush border vesicles
from rabbits with metabolic acidosis.
American Journal of Physiology, 247:
F339-F343.
5. Akiba T, Rocco VK & Warnock DG (1987).
Parallel adaptation of the rabbit renal cor-
tical sodium/proton antiporter and so-
dium/bicarbonate cotransporter in meta-
bolic acidosis and alkalosis. Journal of
Clinical Investigation, 80: 308-315.
6. Krapf R, Pearce D, Lynch C, Xi XP,
Reudelhuber TL, Pouysségur J & Rector
Jr FC (1991). Expression of rat renal Na/H
antiporter mRNA levels in response to
respiratory and metabolic acidosis. Jour-
nal of Clinical Investigation, 87: 747-751.
7. Liu FY & Cogan MG (1987). Angiotensin II
stimulation of hydrogen ion secretion in
the rat early proximal convoluted tubule.
Journal of Clinical Investigation, 80: 272-
275.
8. Halperin ML, Goldstein MB, Richardson
RMA & Stinebaugh BJ (1985). Distal renal
tubular acidosis syndromes: A pathophysi-
ological approach. American Journal of
Nephrology, 5: 1-8.
113
Braz J Med Biol Res 32(1) 1999
Diabetes and thyroparathyroidectomy
9. Kamel KS, Briceno LF, Sanchez MI,
Brenes L, Yorgin P, Kooh SW, Balfe JW &
Halperin ML (1997). A new classification
for renal defects in net acid excretion.
American Journal of Kidney Diseases, 29:
136-146.
10. Pollock CA, Lawrence JR & Field MJ
(1991). Tubular sodium handling and
tubuloglomerular feedback in experimen-
tal diabetes mellitus. American Journal of
Physiology, 260: F946-F952.
11. Ku DD, Sellers BM & Meezan E (1986).
Development of renal hypertrophy and in-
creased renal Na+ K+ATPase in streptozo-
cin-diabetic rats. Endocrinology, 119: 672-
679.
12. Khadouri C, Barlet-Bas C & Doucet A
(1987). Mechanism of increased tubular
Na+-K+-ATPase during streptozotocin-in-
duced diabetes. Pflügers Archives, Euro-
pean Journal of Physiology, 409: 296-301.
13. Xia P, Inoguchi T, Kern TS, Engeman RL,
Oates PJ & King GL (1994). Characteriza-
tion of the mechanism for the chronic
activation of diacyl-glycerol- protein kinase
C pathways in diabetes and hypergalacto-
semia. Diabetes, 43: 1122-1129.
14. Craven PA & DeRubertis FR (1989). Pro-
tein kinase C is activated in glomeruli from
streptozotocin diabetic rats. Journal of
Clinical Investigation, 83: 1667-1675.
15. Pollock AS, Warnock DG & Strewler GJ
(1986). Parathyroid hormone inhibition of
Na-H antiporter in a cultured renal cell
line. American Journal of Physiology, 245:
F450-F461.
16. Bichara M, Mercier O, Paillard M & Leviel
F (1986). Effects of parathyroid hormone
on urinary acidification. American Journal
of Physiology, 251: F444-F453.
17. Wongsurawat N, Armbrecht JH & Siegel
NA (1991). Effects of diabetes mellitus on
parathyroid hormone-stimulated protein
kinase activity, ferrodoxin phosphorylation
and renal 1,25-dihydroxyvitamin D produc-
tion. Journal of Laboratory and Clinical
Medicine, 117: 319-324.
18. Jara A, Bover J & Felsenfeld AJ (1995).
Development of secondary hyperparathy-
roidism and bone disease in diabetic rats
with renal failure. Kidney International, 47:
1746-1751.
19. Akmal M, Kasim SE, Soliman AR &
Massry SG (1990). Excess parathyroid hor-
mone adversely affects lipid metabolism
in chronic renal failure. Kidney Interna-
tional, 37: 854-858.
20. Fuehr J, Kaczmarczyk J & Hrüttgen CD
(1955). Eine einfache colorimetrische
Methode zur Inulinbestimmung für
Nieren-Clearance-Untersuchungen bei
Stoffwechsegesunden und Diabetikern.
Klinische Wochenschrift, 33: 729-730.
21. Smith HW, Finkelstein N, Aliminosa L,
Crawford B & Graber M (1945). The renal
clearances of substituted hippuric acid
derivatives and other aromatic acids in
dogs and man. Journal of Clinical Investi-
gation, 24: 388-404.
22. Connerty VA, Angles MD, Briggs R &
Eaton EH (1957). Determination of pre-
formed urinary ammonia (nitrogen) by
means of direct nesslerization. American
Journal of Clinical Pathology, 28: 634-638.
23. Wongsurawat N & Armbrecht JH (1991).
Calcitonin stimulates 1,25 dihydroxyvita-
min D production in diabetic rat kidney.
Metabolism, 40: 22-25.
24. Martinez I, Saracho R, Moina I,
Montenegro J & Llach F (1998). Is there a
lesser hyperparathyroidism in diabetic pa-
tients with chronic renal failure? Nephrol-
ogy, Dialysis, Transplantation, 13: 9-11.
25. Sherrard DJ, Hercz G, Pei Y, Maloney NA,
Greenwood C, Manuel A, Saiphoo C,
Fenton SS & Segre GV (1993). The spec-
trum of bone disease in end-stage renal
failure - an evolving disorder. Kidney Inter-
national, 43: 426-435.
26. Hostetter TH, Troy JC & Brenner BM
(1981). Glomerular hemodynamics in ex-
perimental diabetes. Kidney International,
19: 410-415.
27. Zatz R, Dunn BR, Meyer TW, Andersen S,
Rennke HG & Brenner BM (1986). Pre-
vention of diabetic glomerulopathy by
pharmacological amelioration of glomeru-
lar capillary hypertension. Journal of Clini-
cal Investigation, 77: 1925-1930.
28. Musso MJ, Barthelmebs M, Imbs JL,
Plante M, Bollack C & Helwig JJ (1989).
The vasodilator action of parathyroid hor-
mone fragments on isolated perfused rat
kidney. Naunyn-Schmiedeberg’s Archives
of Pharmacology, 340: 246-251.
29. Carney SL & Gillies HB (1995). Acute ef-
fect of parathyroid hormone on urine con-
centration in the rat. Clinical Science, 88:
197-201.
30. El-Seifi S, Freiberg JM, Kinsella J, Cheng
L & Sacktor B (1987). Na+-H+ exchange
and Na+-dependent transport systems in
streptozocin diabetic rat kidneys. Ameri-
can Journal of Physiology, 252: R40-R47.
31. Harris RC, Brenner BM & Seifter JL
(1986). Sodium-hydrogen exchange and
glucose transport in renal microvillus
membrane vesicles from rats with diabe-
tes mellitus. Journal of Clinical Investiga-
tion, 77: 724-733.
32. Zaladek Gil F, Costa Silva VL & Malnic G
(1995). Effect of luminal calcium on proxi-
mal tubule reabsorption in the rat. Renal
Physiology and Biochemistry, 18: 271-
277.
33. Wongsurawat N & Armbrecht HJ (1985).
Insulin modulates the stimulation of renal
1,25-dihydroxyvitamin D3 production by
parathyroid hormone. Acta Endocrinolo-
gica, 109: 243-248.
34. Ng LL, Simmons D, Frighi V, Garrido MC,
Bomford J & Hockaday TDR (1990). Leu-
cocyte Na+/H+ antiport activity in Type 1
(insulin-dependent) diabetic patients with
nephropathy. Diabetologia, 33: 371-377.
35. Dumlay R & Hruska K (1990). PTH recep-
tor coupling to phospholipase C is an al-
ternative pathway of transduction in bone
and kidney. American Journal of Physiol-
ogy, 27: F223-F231.
36. Demerdash TM, Seyrek N, Smogorzewski
M, Marchinowski W, Nasser-Moadeli S &
Massry SG (1996). The pathways through
which glucose induces a rise in [Ca]i of
PMNLs of rats. Kidney International, 50:
2032-2040.
37. Tanaka H, Smogorzewski M, Koss M &
Massry SG (1995). Pathways involved in
PTH-induced rise in cytosolic Ca2+ con-
centration of rat proximal tubule. Ameri-
can Journal of Physiology, 268: F330-
F337.
38. Zaladek Gil F, Costa Silva VL, Oshiro MEM
& Ferreira AT (1997). Effects of PTH on
intracellular calcium of MDCK cells in cul-
ture. Cell Physiology and Biochemistry, 7:
35-42.
